CORLINE BIOMEDICAL AB revenue for the last year amounted to 25.00 M SEK, the most of which — 25.03 M SEK — came from its highest performing source at the moment, Heparin Based Solutions, the year earlier bringing 23.55 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought CORLINE BIOMEDICAL AB 25.03 M SEK, and the year before that — 23.55 M SEK.